We are live on
!
Find out more
Wealth Enhancement Advisory Services Portfolio holdings
AUM
$59.8B
1-Year Est. Return
29.42%
This Fund
S&P 500
This Quarter
Est. Return
+2.37%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$42.1B
AUM Growth
+$3.44B
(+8.9%)
Cap. Flow
+$2.79B
Cap. Flow
% of AUM
6.62%
Top 10 Holdings %
Top 10 Hldgs %
24.58%
Holding
2,731
New
249
Increased
1,399
Reduced
845
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$183M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$177M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$129M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$123M |
| 5 |
Apple
AAPL
|
+$87.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
|
+$45.8M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$33.7M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$32.2M |
| 4 |
JNPR
Juniper Networks
JNPR
|
+$26.6M |
| 5 |
Prologis
PLD
|
+$25.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.2% |
| 2 | Financials | 5.64% |
| 3 | Healthcare | 4.49% |
| 4 | Industrials | 3.95% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
iShares iBonds Dec 2029 Term Treasury ETF
IBTJ
$1.35B
| $200K | ﹤0.01% |
+9,367
| New | +$199K |
|
2302
Century Therapeutics
IPSC
$361M
| $199K | ﹤0.01% |
78,234
+19
| +0% | +$60 |
|
2303
Snap
SNAP
$9.01B
| $198K | ﹤0.01% |
11,928
+1,713
| +17% | +$24.6K |
|
|
AFB
2304
AllianceBernstein National Municipal Income Fund
AFB
$317M
| $197K | ﹤0.01% |
17,735
+4,105
| +30% | +$44.2K |
|
2305
Iovance Biotherapeutics
IOVA
$2.87B
| $196K | ﹤0.01% |
24,471
+3,565
| +17% | +$38.2K |
|
2306
Kinross Gold
KGC
$32.8B
| $196K | ﹤0.01% |
23,508
+3,311
| +16% | +$24K |
|
|
ENLC
2307
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $194K | ﹤0.01% |
14,132
-1,471
| -9% | -$19.6K |
|
2308
Zentalis Pharmaceuticals
ZNTL
$302M
| $192K | ﹤0.01% |
47,045
+3,870
| +9% | +$43.2K |
|
2309
Patterson-UTI
PTEN
$3.76B
| $192K | ﹤0.01% |
18,538
+2,086
| +13% | +$22.9K |
|
2310
ALX Oncology
ALXO
$290M
| $189K | ﹤0.01% |
+31,419
| New | +$386K |
|
|
PKST
2311
DELISTED
Peakstone Realty Trust
PKST
| $186K | ﹤0.01% |
17,574
-2,052
| -10% | -$27K |
|
2312
Viavi Solutions
VIAV
$9.66B
| $185K | ﹤0.01% |
26,866
-4,618
| -15% | -$35.9K |
|
2313
BlackRock Corporate High Yield Fund
HYT
$1.37B
| $184K | ﹤0.01% |
19,033
+4,780
| +34% | +$46.4K |
|
2314
QuantumScape Corp
QS
$3.74B
| $184K | ﹤0.01% |
37,472
-14,076
| -27% | -$78.5K |
|
2315
Geron
GERN
$949M
| $181K | ﹤0.01% |
42,805
-112
| -0.3% | -$437 |
|
2316
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
| $181K | ﹤0.01% |
24,253
-3,255
| -12% | -$23.4K |
|
2317
Westwood Holdings Group
WHG
$190M
| $181K | ﹤0.01% |
14,861
| – | – |
|
2318
Leggett & Platt
LEG
$1.31B
| $181K | ﹤0.01% |
+15,789
| New | +$223K |
|
2319
ADT
ADT
$5.58B
| $181K | ﹤0.01% |
+23,788
| New | +$165K |
|
2320
Vale
VALE
$62.6B
| $180K | ﹤0.01% |
16,094
+1,716
| +12% | +$20.6K |
|
2321
Invesco
IVZ
$13.9B
| $179K | ﹤0.01% |
+11,950
| New | +$184K |
|
2322
Vestis
VSTS
$1.88B
| $178K | ﹤0.01% |
+14,563
| New | +$210K |
|
2323
Oscar Health
OSCR
$8.61B
| $177K | ﹤0.01% |
11,184
+550
| +5% | +$10.1K |
|
2324
Nuveen Multi-Asset Income Fund
NMAI
$485M
| $173K | ﹤0.01% |
14,008
+236
| +2% | +$2.86K |
|
|
ETV
2325
Eaton Vance Tax-Managed Buy-Write Opportunities Fund
ETV
$1.76B
| $171K | ﹤0.01% |
12,502
-5,506
| -31% | -$71.5K |
|
Similar funds
QCM
NAMI
Wealth Enhancement Advisory Services's Q2 2024 Portfolio in Review
As of Q2 2024, Wealth Enhancement Advisory Services held 2,731 positions worth $42.1B, up 8.9% from $38.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wealth Enhancement Advisory Services deployed $2.79B of net new capital in Q2 2024, opening 249 new positions and adding to 1,399 existing holdings. Its largest new stake was JPMorgan Short Duration Core Plus ETF: 677,088 shares worth $31.4M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was WisdomTree Yield Enhanced US Aggregate Bond Fund, an estimated $45.8M trimmed.
- Wealth Enhancement Advisory Services's largest Q2 2024 buy was JPMorgan Short Duration Core Plus ETF: 677,088 shares worth $31.4M.
- Wealth Enhancement Advisory Services added most to Vanguard S&P 500 ETF in Q2 2024, an estimated $183M increase.
- Wealth Enhancement Advisory Services's biggest Q2 2024 reduction was WisdomTree Yield Enhanced US Aggregate Bond Fund, cutting an estimated $45.8M.
- Wealth Enhancement Advisory Services fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $32.2M.
- Wealth Enhancement Advisory Services's ten largest holdings make up 25% of its $42.1B portfolio in Q2 2024.
- Wealth Enhancement Advisory Services opened 249 new positions and closed 114 in Q2 2024.
- Wealth Enhancement Advisory Services's portfolio value rose 8.9% quarter-over-quarter to $42.1B.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2024, filed 16 Jul 2024.